secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2026-09-16T21:15:42+00:00
Accession:  0001493152-26-042954
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Matina's BioPharma announces 1-for-15 reverse stock split effective Sept 28, 2026
--------------------------------------------------------------------------------

- Board approved 1-for-15 reverse stock split; effective 12:01 a.m. ET on Sept 28, 2026.
- Trading on split-adjusted basis under symbol MTNB begins Sept 28; new CUSIP 576810 402.
- No fractional shares issued; stockholders receive proportional cash instead.
- Percentage ownership and voting power unchanged; authorized shares and par value unaffected.
- Company notes no assurance split will enable continued NYSE American listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315226042954/0001493152-26-042954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315226042954/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer